Applied Radiation and Isotopes 2011-12-01

Studies for the application of boron neutron capture therapy to the treatment of differentiated thyroid cancer.

A Dagrosa, M Carpano, M Perona, L Thomasz, S Nievas, R Cabrini, G Juvenal, M Pisarev

Index: Appl. Radiat. Isot. 69(12) , 1752-5, (2011)

Full Text: HTML

Abstract

The aim of these studies was to evaluate the possibility of treating differentiated thyroid cancer by BNCT. These carcinomas are well controlled with surgery followed by therapy with (131)I; however, some patients do not respond to this treatment. BPA uptake was analyzed both in vitro and in nude mice implanted with cell lines of differentiated thyroid carcinoma. The boron intracellular concentration in the different cell lines and the biodistribution studies showed the selectivity of the BPA uptake by this kind of tumor.Copyright © 2011 Elsevier Ltd. All rights reserved.

Related Compounds

  • 4-Borono-L-phenyl...

Related Articles:

Pharmacokinetic analysis and uptake of 18F-FBPA-Fr after ultrasound-induced blood-brain barrier disruption for potential enhancement of boron delivery for neutron capture therapy.

2014-04-01

[J. Nucl. Med. 55(4) , 616-21, (2014)]

Low dose of gamma irradiation enhanced boronophenylalanine uptake in head and neck carcinoma cells for boron neutron capture therapy.

2011-12-01

[Appl. Radiat. Isot. 69(12) , 1728-31, (2011)]

Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.

2010-01-01

[BMC Cancer 10 , 661, (2010)]

Boron neutron capture therapy for clear cell sarcoma (CCS): biodistribution study of p-borono-L-phenylalanine in CCS-bearing animal models.

2011-12-01

[Appl. Radiat. Isot. 69(12) , 1721-4, (2011)]

EORTC trial 11001: distribution of two 10B-compounds in patients with squamous cell carcinoma of head and neck, a translational research/phase 1 trial.

2009-08-01

[J. Cell. Mol. Med. 13(8B) , 1653-65, (2009)]

More Articles...